Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||
| Net Income | -12,207 | 0 |
| Depreciation Amortization | 30,924 | 0 |
| Other Working Capital | 2,852 | 0 |
| Other Operating Activity | 23,618 | 0 |
| Operating Cash Flow | $45,187 | $0 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -2,561 | 0 |
| Other Investing Activity | -3,540 | 0 |
| Investing Cash Flow | $-6,101 | $0 |
| Cash Flows From Financing Activities | ||
| Dividend Paid | -7,846 | 0 |
| Other Financing Activity | -5,410 | 0 |
| Financing Cash Flow | $-13,256 | $0 |
| Exchange Rate Effect | -160 | 0 |
| Beginning Cash Position | 17,104 | 0 |
| End Cash Position | 42,774 | 0 |
| Net Cash Flow | $25,670 | $0 |
| Free Cash Flow | ||
| Operating Cash Flow | 45,187 | 0 |
| Free Cash Flow | 45,187 | 0 |